Skip to main content

Advertisement

SpringerLink
Log in

ASO Author’s Reflections: Are Genomic Assays Informing the Management of Ductal Carcinoma in situ as They Have for Invasive Breast Cancer?

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chabner E, Schnitt S, Harris J. Current management of patients with ductal carcinoma in situ. Oncologist. 1997;2(2):76–82.

    Article  CAS  Google Scholar 

  2. Sagara Y, Mallory MA, Wong S, et al. Survival benefit of breast surgery for low-grade ductal carcinoma in situ: a population-based cohort study. JAMA Surg. 2015;150(8):739–45.

    Article  Google Scholar 

  3. Giuliano AE, Edge SB, Hortobagyi GN. Eighth edition of the AJCC Cancer Staging Manual: breast cancer. Ann Surg Oncol. 2018;25(7):1783–5.

    Article  Google Scholar 

  4. Rakovitch E, Nofech-Mozes S, Hanna W, et al. A population-based validation study of the DCIS score predicting recurrence risk in individuals treated by breast-conserving surgery alone. Breast Cancer Res Treat. 2015;152(2):389–98.

    Article  Google Scholar 

  5. Manders JB, Kuerer HM, Smith BD, et al. Clinical utility of the 12-gene DCIS score assay: impact on radiotherapy recommendations for patients with ductal carcinoma in situ. Ann Surg Oncol. 2017;24(3).660–8.

  6. Piltin MA, Hoskin TL, Day CN, Shumway DA, Habermann EB, Davis J, Boughey JC. Use of the twelve-gene recurrence score for ductal carcinoma in situ and its influence on receipt of adjuvant radiation and hormonal therapy. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-020-09517-z.

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Mayo Clinic, Rochester, MN, USA

    Mara A. Piltin DO & Judy C. Boughey MD

Authors
  1. Mara A. Piltin DO
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Judy C. Boughey MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Judy C. Boughey MD.

Ethics declarations

Disclosure

The authors have no conflicts of interest or sources of funding to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Piltin, M.A., Boughey, J.C. ASO Author’s Reflections: Are Genomic Assays Informing the Management of Ductal Carcinoma in situ as They Have for Invasive Breast Cancer?. Ann Surg Oncol 28, 4304–4305 (2021). https://doi.org/10.1245/s10434-020-09573-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-09573-5

Search

Navigation